TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
RPH Pharmaceuticals AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
218,318
|
175,352
|
147,178 |
Financial expenses |
16,935
|
20,749
|
33,980 |
Earnings before taxes |
35,184
|
48,872
|
-2,788 |
EBITDA |
70,491
|
52,367
|
34,271 |
Total assets |
284,417
|
378,012
|
231,456 |
Current assets |
89,600
|
213,923
|
76,912 |
Current liabilities |
241,479
|
322,485
|
179,828 |
Equity capital |
40,174
|
49,930
|
45,616 |
- share capital |
95
|
98
|
105 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
14.1%
|
13.2%
|
19.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
16.1%
|
27.9%
|
-1.9% |
Return on assets (ROA) |
18.3%
|
18.4%
|
13.5% |
Current ratio |
37.1%
|
66.3%
|
42.8% |
Return on equity (ROE) |
87.6%
|
97.9%
|
-6.1% |
Change turnover |
48,236
|
38,343
|
-39,451 |
Change turnover % |
28%
![]() |
28%
|
-21% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.